United BioSource Corp.

• Bioanalytical Testing: This is a core competency of UBC, covering a broad spectrum of analytical techniques to support the development of biotherapeutics and small molecule drugs. This includes pharmacokinetic (PK) and pharmacodynamic (PD) analysis, immunogenicity assessments, and biomarker analysis. Their expertise extends to various matrices, including blood, plasma, serum, tissue, and urine.

• Drug Development Support: UBC provides consulting and support services to assist clients in navigating the complexities of drug development. This might include study design, protocol development, data management, and regulatory submission support. Their experience spans various therapeutic areas.

• Clinical Trial Management: While not explicitly stated as a primary service on their website, their bioanalytical testing and drug development support services strongly suggest involvement in supporting the bioanalytical aspects of clinical trials.

• Regulatory Expertise: Navigating regulatory requirements is crucial in the biopharmaceutical industry. UBC's involvement in drug development strongly suggests a deep understanding of regulatory guidelines and procedures, enabling them to assist clients in meeting these requirements.

The company's client base likely includes large pharmaceutical companies, biotechnology firms, and smaller research organizations. Their success is built on a foundation of scientific expertise, advanced technologies, and a commitment to quality and regulatory compliance. The specific technologies and methodologies employed by UBC would be detailed in their internal documentation and likely vary based on the specific client needs and project requirements. The overall goal of UBC is to assist their clients in efficiently and successfully bringing safe and effective therapeutics to market.